Stock LXEO LEXEO THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Lexeo Therapeutics, Inc.

Equities

LXEO

US52886X1072

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-06-03 EDT 		5-day change 1st Jan Change
17.05 USD +2.53% Intraday chart for Lexeo Therapeutics, Inc. +10.28% +27.05%
05-09 Lexeo Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
05-01 Certain Options of Lexeo Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 1-MAY-2024. CI

Analyst Reco.

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
RBC Raises Price Target on Lexeo Therapeutics to $24 From $22, Cites 'Solid' Friedreich's Ataxia Data; Outperform, Speculative Risk Kept
MT
Chardan Initiates Lexeo Therapeutics With Buy Rating, $23 Price Target
MT
Stifel Starts Lexeo Therapeutics With Buy Rating, $20 Price Target
MT
RBC Initiates Lexeo Therapeutics at Outperform, Speculative Risk With $22 Price Target Amid 'Undemanding' Valuation, Upcoming Catalysts
MT
JPMorgan Starts Lexeo Therapeutics With Overweight Rating, $20 Price Target
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. LXEO Stock
  4. News Lexeo Therapeutics, Inc.
  5. Analyst Reco.